JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nawrath, H.
Right arrow Articles by Shainberg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nawrath, H.
Right arrow Articles by Shainberg, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*VERAPAMIL HYDROCHLORIDE

Vol. 285, Issue 2, 546-552, May 1998

Open State Block by Fendiline of L-Type Ca++ Channels in Ventricular Myocytes from Rat Heart1

Hermann Nawrath, Gunnar Klein, Johanna Rupp, Jörg W. Wegener and Asher Shainberg

Pharmakologisches Institut der Universität Mainz, Obere Zahlbacher Str. 67, D-55101 Mainz, Germany (H.N., G.K., J.R., J.W.W.) and Otto Meyerhoff Center, Department of Life Sciences, Bar-Ilan University, 52900 Ramat-Gan, Israel (A.S.)

The effects of fendiline on L-type Ca++ currents [ICa(L)] were investigated in rat ventricular cardiomyocytes using the patch-clamp technique both in the whole-cell disrupted-patch and in the cell-attached configuration. For comparison, the effects of verapamil were also investigated. Both compounds depressed the magnitude of whole cell ICa(L), verapamil being about 15 times more potent than fendiline. Verapamil did not change the time course of the current, whereas fendiline accelerated its decay when either Ca++ or Ba++ ions were used as charge carriers. In the presence of the Ca++ agonist BayK8644 (10 µM), the potency ratio of fendiline/verapamil was inverted. BayK8644 (10 µM) also reversed the potency ratio of verapamil/fendiline in smooth muscle, with respect to changes in tension induced by K+ (48 mM). In single channel recordings at 0.1 Hz, in the presence of BayK8644 (1 µM) and using Ba++ ions as the charge carrier, fendiline (1 µM) reduced mean open time by 34% and channel availability by 8%; the ensemble average current of Ca++ channels was reduced by 43%. In the same experimental conditions, verapamil (1 µM) was ineffective. These results can be explained by the assumption that fendiline blocks Ca++ channels preferentially in the open state, in contrast to verapamil which blocks preferentially inactivated Ca++ channels.


0022-3565/98/2852-0546$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
C. Huang, C. Huang, J. Cheng, S. Liu, I. Chen, J. Tsai, C. Chou, P. Tseng, and C. Jan
Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells
Human and Experimental Toxicology, January 1, 2009; 28(1): 41 - 48.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox
Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety
Toxicol Pathol, January 1, 2006; 34(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
J-S Cheng, J-L Wang, Y-K Lo, K-J Chou, K-C Lee, C-P Liu, H-T Chang, and C-R Jan
Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells
Human and Experimental Toxicology, July 1, 2001; 20(7): 359 - 364.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.